Comparison of Bone Mineral Density with Biochemical Parameters and Prevalence of Osteopenia and Osteoporosis in South Indian Population

Abstract

Osteoporosis is identifying based on the bone mineral density (BMD). The bone mineral mass or BMD exposes the amount of minerals present in a particular region of bone tissue. BMD measurement by DEXA is consideredas gold standard, but it is very expensive. The people of developing countriesare not interested to check BMD until the occurrence offracture. Therefore present study focusing any association of routine biochemical markers with BMD in osteoporosis and also planning to identify disease distribution status in south India. We examined 773 participants BMD by DEXA scan and grouped into three, Group I (Normal bone mass, n=237), group II (Osteopenia, n=345) and group III (Osteoporosis, n=191). The serum calcium, phosphorous and alkaline phosphatase (ALP) were estimated by automated chemistry analyzer., and Serum 25(OH) vitamin D was analyzed by immunoassay system analyser. The prevalence of normal BMD, osteopenia and osteoporosis was 30.7%, 44.6%and 24.7% respectively.Between 60 and 69 years aged men having more prevalence of osteopenia and in women 50 to 59 years of age. While osteoporosis in men 50 to 59 years and in women’s were 60 to 69 years of age. The serum calcium, ALP and 25 (OH) vitamin D levels were statistically significant (p< 0.001) between the three groups.The higher percentage of low bone mineral density (osteopenia) is the alarming signalto the bone health and this could be continued leads to osteoporosis, which affects the quality of life. This study suggests to determining BMD along with biochemical markers are useful to identify osteoporosis in earlier stage. Therefore routine screening of BMD may prevent the risk of osteoporosis.

Prevalence of osteoporosis in patients with chronic liver disease (CLD) in a hospital; a cross-sectional study

“…The prevalence in women was estimated to be 15%; 4.7% of premenopausal women and 10.3% of post-menopausal women were affected. 9.7% of men in this study were found to be predisposed (Modagan et al, 2018;Zou et al, 2020). The prevalence % was recorded maximum in female than male in the current study which is in line with the previous studies (Ormarsdottir et al, 1999;Cheraghi et al, 2018).…”

The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis

“…Studies in many different countries have demonstrated that with increased communication between the orthopaedist, patient and patient’s PCP, there is increased usage of pharmacotherapeutics, calcium and vitamin D supplementation, and BMD assessment with DXA scan [ 14 – 17 ]. There is also good evidence that the use of calcium, vitamin D and pharmaceutical interventions results in a decreased risk of fragility fractures [ 14 – 17 ].…”

“…The prevalence in women was reported to be 15%; 10.3% was related to post-menopausal women, and 4.7% to premenopausal women. In this study, the prevalence in men was reported to be 9.7% [ 17 ].…”

Preliminary study of distal forearm bone mineral density in residents of Doi Lo District: Observation and comparison with Mae Chaem, and Omkoi Districts, Chiang Mai Province, Thailand

“…It was found to be 9.7%, and 15% for males and females, respectively. 23 Similarly, Marwaha, RK et al 2011 showed that the prevalence of osteoporosis in an Indian population aged at 50 years and above who inhabited Delhi was 35.1%. It was 24.6% and 42.5% for males and females, respectively.…”